Prescription Bupropion Hydrochloride Tablets Recalled for Failed Quality Specifications
Amerisource Health Services LLC is recalling 1,416 cartons of Bupropion Hydrochloride Tablets (75 mg) nationwide due to failed impurities and degradation specifications. The tablets do not meet FDA quality standards for purity.
What this means for you
Real risk of harm even if no illness or injury has been reported yet. Stop using the product and follow the agency's guidance.
Our severity reasoning: This is a Class II drug recall for failed quality specifications (impurities and degradation) with no reported illnesses or injuries. It represents a potential risk of harm from chemical impurities, matching the 'risk-of-harm products where injury has not yet been reported' criterion for Score 3 (High).
Plain-English summary
Amerisource Health Services LLC is recalling 1,416 cartons of Bupropion Hydrochloride Tablets, USP 75 mg nationwide. The product is distributed in 10 x 10 blister packs per carton, with lot number 1003837 and expiration date January 31, 2023. The recall applies to product distributed throughout the United States.
The recall was initiated because the product failed impurities and degradation specifications. The tablets do not meet FDA quality standards for chemical purity and stability.
Consumers who have this medication should consult their healthcare provider or pharmacist about whether to continue using it or obtain a replacement. Patients should not abruptly stop taking Bupropion without medical guidance.
Anyone with questions about this recall can contact their pharmacist or healthcare provider.
The recalled product
- Product
- BUPROPION HYDROCHLORIDE (BUPROPION HYDROCHLORIDE)
- Brand
- BUPROPION HYDROCHLORIDE
- Manufacturer
- Amerisource Health Services LLC
- Category
- Drug
- Hazard
- impurities
- product-degradation
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (2)
- Lot #: 1003837
- Exp. Date 01/31/2023
Distribution
Distributed nationwide across the United States.
Related recalls
Same brand · BUPROPION HYDROCHLORIDE
- HighBupropion Extended-Release Tablets Recalled for Dissolution Failure
FDA (Drugs) · 2024-07-17
- HighFDA recalls Bupropion Hydrochloride tablets for foreign tablet contamination
FDA (Drugs) · 2024-01-17
- ModerateBupropion Hydrochloride Extended-Release Tablets Recalled for Failed Dissolution
FDA (Drugs) · 2023-12-13
- ModerateSun Pharmaceutical Bupropion Extended-Release Tablets Recalled for Failed Dissolution
FDA (Drugs) · 2023-10-25
- HighBupropion Hydrochloride Extended-Release Tablets Recalled for Failed Dissolution Specifications
FDA (Drugs) · 2023-05-31
Same category
- CriticalWarfarin Tablets Recalled After Mix-Up Between 2.5 mg and 5 mg Strengths
FDA (Drugs) · 2026-07-21
- SevereAtomoxetine Capsules Recalled Due to Labeling Mix-Up Error
FDA (Drugs) · 2026-05-27
- SevereCIMZIA injection recalled due to lack of sterility assurance
FDA (Drugs) · 2026-05-27
- LowPrimidone Tablets Recalled Due to Cross-Contamination with Acemetacin
FDA (Drugs) · 2026-05-27
- ModerateVitamin B-Complex, Vitamin C & Folic Acid Dietary Supplement Oral Liquid
FDA (Drugs) · 2026-05-27